Vanguard Group Inc ownership in HTD / Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated

DE ˙ DB ˙ US2183521028

63,98 € ↑2,18 (3,53%)

2026-06-04
PREZZO DELLE AZIONI

Security	DE:HTD / Corcept Therapeutics Incorporated
Institution	Vanguard Group Inc
Latest Disclosed Ownership	0 shares
Ownership	0.00%

2026-03-26 - Vanguard Group Inc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Corcept Therapeutics Incorporated (DE:HTD). This represents 0.0 percent ownership of the company. In their previous filing dated 2024-02-13 , Vanguard Group Inc had reported owning 9,537,532 shares, indicating a decrease of -100.00 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File Date	Effective Date	Form	Prev Shares	Latest Shares	ΔShares (Percent)	Ownership (Percent)	ΔOwnership (Percent)
2026-03-26	2026-03-26	13G/A	9,537,532	0	-100.00	0.00	-100.00
2024-02-13	2024-02-13	13G/A	10,345,030	9,537,532	-7.81	9.25	-3.75
2023-02-09	2023-02-09	13G/A	10,844,789	10,345,030	-4.61	9.61	-6.06
2022-03-09	2022-03-09	13G/A	10,797,477	10,844,789	0.44	10.23	9.41
2022-02-09	2022-02-09	13G/A	11,996,149	10,797,477	-9.99	9.35	-9.49
2021-02-10	2021-02-10	13G/A	11,731,804	11,996,149	2.25	10.33	1.77
2020-10-13	2020-10-13	13G/A	10,948,746	11,731,804	7.15	10.15	5.95
2020-02-12	2020-02-12	13G/A	10,773,994	10,948,746	1.62	9.58	2.68
2019-02-11	2019-02-11	13G/A	9,370,179	10,773,994	14.98	9.33	13.64
2018-02-08	2018-02-08	13G		9,370,179		8.21

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-01-29	2025-12-31	13F	CORCEPT THERAPEUTICS	COM	218352102	9,494,822	-42,249	-0.44	330,420	-58.31	0.0048
2025-11-07	2025-09-30	13F	CORCEPT THERAPEUTICS	COM	218352102	9,537,071	-143,521	-1.48	792,626	11.55	0.0119
2025-08-11	2025-06-30	13F	CORCEPT THERAPEUTICS	COM	218352102	9,680,592	-301,376	-3.02	710,555	-37.68	0.0115
2025-05-09	2025-03-31	13F	CORCEPT THERAPEUTICS	COM	218352102	9,981,968	-133,656	-1.32	1,140,140	123.68	0.0206
2025-02-11	2024-12-31	13F	CORCEPT THERAPEUTICS	COM	218352102	10,115,624	109,294	1.09	509,726	10.07	0.0089
2024-11-13	2024-09-30	13F	CORCEPT THERAPEUTICS	COM	218352102	10,006,330	452,624	4.74	463,093	49.19	0.0083
2024-08-13	2024-06-30	13F	CORCEPT THERAPEUTICS	COM	218352102	9,553,706	-12,076	-0.13	310,400	28.82	0.0060
2024-05-10	2024-03-31	13F	CORCEPT THERAPEUTICS	COM	218352102	9,565,782	28,250	0.30	240,962	-22.21	0.0048
2024-03-11	2023-12-31	13F/A-1	CORCEPT THERAPEUTICS	COM	218352102	9,537,532	239,887	2.58	309,779	22.29	0.0068
2024-02-14	2023-12-31	13F	CORCEPT THERAPEUTICS	COM	218352102	9,537,532	239,887		309,779		0.0059
2023-12-18	2023-09-30	13F/A-1	CORCEPT THERAPEUTICS	COM	218352102	9,297,645	-13,580	-0.15	253,314	22.27	0.0062
2023-11-14	2023-09-30	13F	CORCEPT THERAPEUTICS	COM	218352102	9,297,645	-13,580		253,314		0.0011
2023-08-14	2023-06-30	13F	CORCEPT THERAPEUTICS	COM	218352102	9,311,225	-1,123,519	-10.77	207,175	-8.34	0.0049
2023-07-14	2023-03-31	13F/A-1	CORCEPT THERAPEUTICS	COM	218352102	10,434,744	89,714	0.87	226,017	7.57	0.0058
2023-05-15	2023-03-31	13F	CORCEPT THERAPEUTICS	COM	218352102	10,434,744	89,714		226,017		0.0012
2023-02-10	2022-12-31	13F	CORCEPT THERAPEUTICS	COM	218352102	10,345,030	12,953	0.13	210,108	-20.69	0.0057
2022-11-14	2022-09-30	13F	CORCEPT THERAPEUTICS	COM	218352102	10,332,077	458,414	4.64	264,915	12.83	0.0078
2022-08-12	2022-06-30	13F	CORCEPT THERAPEUTICS	COM	218352102	9,873,663	-565,089	-5.41	234,796	-0.12	0.0066
2022-05-13	2022-03-31	13F	CORCEPT THERAPEUTICS	COM	218352102	10,438,752	-358,725	-3.32	235,081	9.96	0.0056
2022-02-14	2021-12-31	13F	CORCEPT THERAPEUTICS	COM	218352102	10,797,477	-1,073,041	-9.04	213,790	-8.49	0.0049
2021-11-12	2021-09-30	13F	CORCEPT THERAPEUTICS	COM	218352102	11,870,518	-106,866	-0.89	233,612	-11.34	0.0058
2021-08-13	2021-06-30	13F	CORCEPT THERAPEUTICS	COM	218352102	11,977,384	-410,343	-3.31	263,502	-10.59	0.0066
2021-05-14	2021-03-31	13F	CORCEPT THERAPEUTICS	COM	218352102	12,387,727	391,578	3.26	294,704	-6.09	0.0080
2021-02-12	2020-12-31	13F	CORCEPT THERAPEUTICS	COM	218352102	11,996,149	264,345	2.25	313,819	53.69	0.0091
2020-11-16	2020-09-30	13F	CORCEPT THERAPEUTICS	COM	218352102	11,731,804	492,458	4.38	204,192	8.01	0.0068
2020-08-14	2020-06-30	13F	CORCEPT THERAPEUTICS	COM	218352102	11,239,346	121,519	1.09	189,045	43.01	0.0067
2020-05-15	2020-03-31	13F	CORCEPT THERAPEUTICS	COM	218352102	11,117,827	169,081	1.54	132,191	-0.22	0.0056
2020-02-14	2019-12-31	13F	CORCEPT THERAPEUTICS	COM	218352102	10,948,746	42,085	0.39	132,479	-14.07	0.0045
2019-11-14	2019-09-30	13F	CORCEPT THERAPEUTICS	COM	218352102	10,906,661	-41,458	-0.38	154,166	26.29	0.0057
2019-08-14	2019-06-30	13F	CORCEPT THERAPEUTICS	COM	218352102	10,948,119	12,558	0.11	122,072	-4.92	0.0046
2019-05-15	2019-03-31	13F	CORCEPT THERAPEUTICS	COM	218352102	10,935,561	161,567	1.50	128,383	-10.81	0.0050
2019-02-14	2018-12-31	13F	CORCEPT THERAPEUTICS	COM	218352102	10,773,994	411,434	3.97	143,940	-0.92	0.0065
2018-12-13	2018-09-30	13F/A-2	CORCEPT THERAPEUTICS	COM	218352102	10,362,560	37,781	0.37	145,283	-10.49	0.0057
2018-11-23	2018-09-30	13F/A-1	CORCEPT THERAPEUTICS	COM	218352102	10,362,560	0		145,283		0.0057
2018-11-14	2018-09-30	13F	CORCEPT THERAPEUTICS	COM	218352102	10,362,560	37,781		145,283
2018-08-14	2018-06-30	13F	CORCEPT THERAPEUTICS	COM	218352102	10,324,779	1,573,511	17.98	162,306	12.75	0.0068
2018-05-15	2018-03-31	13F	CORCEPT THERAPEUTICS	COM	218352102	8,751,268	-618,911	-6.61	143,958	-14.93	0.0063
2018-02-14	2017-12-31	13F	CORCEPT THERAPEUTICS	COM	218352102	9,370,179	3,134,600	50.27	169,226	40.61	0.0074
2017-11-14	2017-09-30	13F	CORCEPT THERAPEUTICS	COM	218352102	6,235,579	1,795,515	40.44	120,348	129.70	0.0056
2017-08-24	2017-06-30	13F/A-1	CORCEPT THERAPEUTICS	COM	218352102	4,440,064	689,554	18.39	52,394	27.46	0.0026
2017-08-11	2017-06-30	13F	CORCEPT THERAPEUTICS	COM	218352102	4,440,064	689,554		52,394
2017-05-12	2017-03-31	13F	CORCEPT THERAPEUTICS	COM	218352102	3,750,510	359,177	10.59	41,106	66.96	0.0021
2017-02-14	2016-12-31	13F	CORCEPT THERAPEUTICS	COM	218352102	3,391,333	307,569	9.97	24,620	22.83	0.0014
2016-11-14	2016-09-30	13F	CORCEPT THERAPEUTICS	COM	218352102	3,083,764	104,029	3.49	20,044	23.20	0.0012
2016-08-10	2016-06-30	13F	CORCEPT THERAPEUTICS	COM	218352102	2,979,735	193,729	6.95	16,269	24.77	0.0010
2016-05-13	2016-03-31	13F	CORCEPT THERAPEUTICS	COM	218352102	2,786,006	25,697	0.93	13,039	-5.14	0.0008
2016-02-08	2015-12-31	13F	CORCEPT THERAPEUTICS	COM	218352102	2,760,309	57,086	2.11	13,746	35.24	0.0009
2015-11-12	2015-09-30	13F/A-1	CORCEPT THERAPEUTICS	COM	218352102	2,703,223	75,636	2.88	10,164	-35.64	0.0004
2015-11-12	2015-09-30	13F/A-1	CORCEPT THERAPEUTICS	COM	218352102	2,703,223	75,636		10,164		0.0004
2015-11-12	2015-09-30	13F	CORCEPT THERAPEUTICS	COM	218352102	7,139,009			168,568
2015-08-13	2015-06-30	13F	CORCEPT THERAPEUTICS	COM	218352102	2,627,587	378,204	16.81	15,792	25.37	0.0011
2015-05-15	2015-03-31	13F/A-1	CORCEPT THERAPEUTICS	COM	218352102	2,249,383	47,087	2.14	12,596	90.65	0.0009
2015-05-14	2015-03-31	13F	CORCEPT THERAPEUTICS	COM	218352102	2,249,383			12,596
2015-02-12	2014-12-31	13F	CORCEPT THERAPEUTICS	COM	218352102	2,202,296	45,413	2.11	6,607	14.31	0.0005
2014-11-12	2014-09-30	13F	CORCEPT THERAPEUTICS	COM	218352102	2,156,883	8,639	0.40	5,780	-3.92	0.0005
2014-08-11	2014-06-30	13F	CORCEPT THERAPEUTICS	COM	218352102	2,148,244	18,849	0.89	6,016	-35.20	0.0005
2014-05-13	2014-03-31	13F	CORCEPT THERAPEUTICS	COM	218352102	2,129,395	222,944	11.69	9,284	51.25	0.0008
2014-02-12	2013-12-31	13F	CORCEPT THERAPEUTICS	COM	218352102	1,906,451	-94,507	-4.72	6,138	92.90	0.0005
2013-11-07	2013-09-30	13F	CORCEPT THERAPEUTICS	COM	218352102	2,000,958	20,184	1.02	3,182	-7.15	0.0003
2013-08-13	2013-06-30	13F	CORCEPT THERAPEUTICS	COM	218352102	1,980,774	1,980,774		3,427		0.0004

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.